In this study we tested the relationship of sclerostin both with vascular damage and brain atrophy in the whole sample, considering together hypertensive and non-hypertensive patients, and also in the subgroups of hypertensive and non-hypertensive patients, these last lacking a classic major risk factor for vascular damage. This evidence concerns the gene SOST and Brain atrophy.